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Objective: To investigate changes after a mountain ultramarathon (MUM) in the serum concentration of fast (FM) and slow (SM) 
myosin isoforms, which are fiber-type-specific sarcomere proteins. The changes were compared against creatine kinase (CK), a 
widely used fiber-sarcolemma-damage biomarker, and cardiac troponin I (cTnI), a widely used cardiac biomarker. Methods: 
Observational comparison of response in a single group of 8 endurance-trained amateur athletes. Time-related changes in serum 
levels of CK, cTnI, SM, and FM from competitors were analyzed before, 1 h after the MUM, and 24 and 48 h after the start of the 
MUM by 1-way ANOVA for repeated measures or Friedman and Wilcoxon tests. Pearson correlation coefficient was employed to 
examine associations between variables. Results: While SM was significantly (P = .009) increased in serum 24 h after the beginning 
of the MUM, FM and cTnI did not change significantly. Serum CK activity peak was observed 1 h after the MUM (P = .002). 
Moreover, serum peaks of CK and SM were highly correlated (r = .884, P = .004). Conclusions: Since there is evidence of muscle 
damage after prolonged mountain running, the increase in SM serum concentration after a MUM could be indirect evidence of slow- 
(type I) fiber-specific sarcomere disruptions. 
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Mountain ultramarathons (MUM) are competitive events 1 con-
sisting of walking and running on mountain trails over a great cumu-
lative elevation gain and over a longer distance than the athletic mara-
thon (>42.195 km). Distance and cumulative elevation gain are the 
main determinants of MUM difficulty. Long-distance trail competi-
tions have risen in popularity over the last few years.1 However, the 
acute physiological responses to extreme endurance events still re-
main unclear. It is known that MUM competitions are strenuous and 
generally include negative slopes, so long distances are run downhill. 
It has been stated that strenuous exercise can result in muscle dam-
age,2 which is particularly exacerbated if eccentric contractions are 
performed (for a review see Proske and Allen3). Downhill running 
increases the eccentric component because the peak flexion angles are 
significantly greater, and it is a much stronger stimulus for damage 
than level or uphill running.4 Therefore, it seems reasonable to relate 
most of the muscle damage to the negative-slope phases of the trail. 
MUM is a great opportunity for field-specific assessments of a physi-
ologically stressful competitive event that induces muscle damage.5,6 
Direct evaluation of muscle damage involves histological 
examination of muscle tissue by biopsy. However, in a sports context, 
the analysis of exercise-induced muscle damage is essentially based 
on proxy markers such as measurements of enzyme activity in blood, 
especially the activity of creatine kinase (CK). Previous studies 
evaluated the muscle damage induced by MUMs5,6 and revealed large 
increases in total CK concentrations. However, CK is not a specific 
biomarker of skeletal muscle.7 Koller et al8 used slow (type I) myosin 
heavy-chain (MHC) fragments, and Melin et al9 used beta MHC as 
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muscle-fiber-specific damage biomarkers. Those groups found 
increases in this protein in plasma after mountain-running events. 
Although slow (type I) MHC fragments and beta MHC are common 
to skeletal and cardiac muscle, the damage was mainly related to slow 
(type I) fibers of skeletal muscle. However, the results found by 
Koller et al8 and Melin et al9 were highly unspecific, since plasma 
levels of MHC fragments were not compared with any cardiac-
specific biomarker. Since it has been stated that strenuous exercise 
could induce a significant release of cardiac proteins such as troponin 
into the bloodstream,10 it seems reasonable to assume that proteins 
found in cardiac and skeletal muscle, such as MHC fragments and 
beta MHC, could also be released from myocardium to blood. 
Recently, myosin isoforms have been proposed as fiber-type-
specific biomarkers of muscle damage that would represent indirect 
evidence of sarcomere disruptions.11 However, Carmona et al11 
observed selective release of fast myosin isoforms (FM) after high-
intensity knee-extensor exercise, but no changes in slow-myosin-
isoform (SM) serum concentration were reported. SM is found in both 
cardiac and skeletal muscle, and FM is characteristic of fast skeletal 
muscle. Limb skeletal muscles are composed of slow (type I) and fast 
(type II) fibers,12 but adult skeletal muscles shows plasticity and can 
undergo conversion between different fiber types in response to 
exercise.13 Endurance athletes tend to have a predominance of slow 
(type I) fibers.14,15 For these reasons, we hypothesized that serum 
increases in myosin isoforms, especially in SM, in endurance-trained 
participants after a MUM could indicate not only the extent but also 
the type of fiber affected. Furthermore, in the current study, the lack 
of specificity of SM was minimized by analyzing the changes in 
serum concentration of cardiac troponin I (cTnI), a widely used 
myocardial-specific biomarker. It has been shown that cTnI is 
released after prolonged exercise. However, in contrast to myocardial 
infarction, in which cTnI is usually over 0.6 ng/mL and remains 
stable in blood for at least 5 days, cTnI release after prolonged 
exercise does not achieve such high serum levels and returns to 
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baseline within 24 to 48 hours.16 To the best of our knowledge, this is 
the first field study to use a combination of myosin isoforms and cTnI 
to assess indirectly the muscle damage induced by a MUM. 
The aim of this study was to investigate changes in serum 
concentration of myosin isoforms after a MUM. SM and FM were 
compared with CK, a widely used biomarker of exercise-induced 
muscle damage. The lack of specificity of SM was countered with the 
measurement of serum cTnI concentration. Since there is evidence of 
muscle damage after prolonged mountain running,5,6 we hypothesized 
that a specific increase in SM serum concentration after a MUM 
would be indirect evidence of slow (type I) -fiber sarcomere damage 
in endurance-trained mountain runners. 
Methods 
Participants 
We initially recruited 17 endurance runners, 14 men and 3 women. 
However, due to bad weather conditions during the competition, only 
8 subjects decided to complete the study: 7 men and 1 woman (mean 
± SD; men, n = 7, 39.8 ± 3.3 y, 178.7 ± 5.2 cm, 76.9 ± 7.9 kg; 
women, n = 1, 39.1 y, 173.0 cm, 67.0 kg). All of the participants were 
experienced white nonprofessional athletes (mean training regimen, 
450.0 ± 210.31 min/wk of endurance training) who were specifically 
trained for MUM. All were healthy and had incurred no muscle 
injuries in the 6 months before the study. To avoid bias, no 
instructions were given about the type of training performed the week 
before the competition, but athletes were asked about it to better 
interpret the baseline serum levels of enzymes and contractile 
proteins. Physical activity after the race was limited and massages 
were prohibited. The study conformed to the Declaration of Helsinki 
for medical research, participants provided written informed consent, 
and the research was approved by the ethics committee of the Catalan 
Sports Council (Government of Catalonia). 
Design 
The study design used observational comparison of response in a 
single group of endurance-trained amateur athletes. 
Methodology 
The participants ran in the “Cavalls del Vent” MUM in 2012, an 
official competition organized by Salomon Nature Trails. It was a 
circular route with an official length of 84.84 km (~85 km) and a total 
cumulative elevation gain of 12,180 m. The start of the race was at 
755 m above sea level and the maximum summit achieved during the 
trail was 2520 m (Figure 1). Each runner’s average speed was 
calculated according to the total distance run divided by his or her 
official time. 
\<<<<<<<<<FIGURE 1>>>>>>>>>>>>>\ 
Four blood samples were obtained: 1 day before the 
competition (pre), less than 1 hour after finishing the competition 
(post), and, because a significant degree of damage can occur during 
the race, 24 and 48 hours after the beginning of the MUM. A 5-mL 
blood sample was drawn from an antecubital vein. Blood was allowed 
to clot for 30 minutes in a tube (SST II Advance, Becton Dickinson 
Vacutainer Systems, UK) before being centrifuged at 3000 g for 10 
minutes at 4°C. Three 200- L aliquots of serum were stored at –80°C 
until analysis. 
CK determinations were performed in an Advia 2400 automatic 
device (Siemens Medical Solutions Diagnostics, Tarrytown, NY, 
USA), and cTnI determinations were made in a Dimension Clinical 
Chemistry System automatic device (Siemens Healthcare 
Diagnostics, Tarrytown, NY, USA) with an analytical measurement 
range of 0.017 to 40 ng/mL. To obtain muscle myosin-isoform 
concentrations in serum, we developed an enzyme-linked 
immunosorbent assay (ELISA-sandwich), which is described 
elsewhere.11 Briefly, a calibration curve was obtained by a serial 
dilution from 0 to 250 ng of pure myosin from porcine muscle 
M0273, and the ELISA was completed by using monoclonal 
antimyosin (skeletal, fast) clone My-32, monoclonal antimyosin 
(skeletal, slow) clone NOQ7.5.4D, antimyosin polyclonal antibody 
M7523, and mouse anti-IGG linked to peroxidase A6154 (all Sigma 
Aldrich, Poole, UK). Intra-assay coefficients of variation were below 
8% for FM and below 7.5% for SM. The linearity of the FM assay 
results was 80%, and it was 90% for the SM assay. 
Statistical Analyses 
The normality of each variable was tested using the Shapiro-Wilk 
test. As SM and CK were asymmetrically distributed, these variables 
were log-transformed before analysis. One-way repeated-measures 
ANOVA was used to identify the effect of time on CK activity and 
SM and FM serum levels. When any significant main effects were 
found, pairwise t-test comparisons with a Bonferroni correction were 
used. The time course of changes in cTnI serum concentration was 
evaluated with the use of Friedman and Wilcoxon nonparametric 
tests. Effect sizes (ES) (Cohen d) were calculated to determine the 
practical difference between baseline values and serum peaks of 
enzymes and proteins. ES values of above 0.8, 0.8 to 0.5, 0.5 to 0.2, 
and lower than 0.2 were considered large, moderate, small, and 
trivial, respectively. Pearson correlation coefficient was employed to 
evaluate the association between the variables of interest. Data are 
presented as mean ± standard error of the mean unless otherwise 
stated. The level of significance was set at P < .01. All statistical 
analyses were conducted using SPSS version 20.0 statistical-analysis 
software (SPSS Statistics, IBM Corp, Armonk, NY). 
Results 
The week before the competition, participants reported the use of 
similar training strategies, based on a decrease in training volume 
(km/wk) and an increase in intensity (running average velocity). At 
the competition, only 1 participant finished the MUM (~85 km). The 
rest of the participants left the competition at different points along 
the trail due to bad weather conditions: temperature, range 0.9°C to 
13.1°C; rain, range 0 to 6.1 mm/h; humidity, range 90% to 97%; and 
wind speed (east-southeast), range 1.1 to 5 m/s. The total distance 
(km) covered and official time (h:min:s) of each participant who 
decided to carry on with the study protocol were determined by the 
last official control point passed just before leaving the MUM. 
Individual average speed (km/h) was calculated according to these 
results (Table 1). With respect to biochemical markers, the average 
serum CK activity at baseline was in the clinically normal range (35–
175 U/L) and rose significantly from 132 ± 22 U/L (pre) to a peak of 
2052 ± 860 U/L (ES = 3.02) less than 1 hour after finishing the 
MUM. Average CK serum activity remained significantly elevated 24 
hours (1345 ± 651 U/L) (ES = 2.59) after the beginning of the 
competition, but a clear decreasing trend was observed (Figure 2). 
The only woman who participated in the study until the end and also 
completed the whole long-distance trail (participant number 7) had 
the highest values of CK in serum in all samples (Table 1). Almost all 
participants were in the clinically normal range of cTnI (<0.017–
0.050 ng/mL), or slightly above, in all analyzed samples (Table 1). 
No significant increase was seen in average cTnI serum 
concentrations 1 hour after the MUM (from 0.018 ± 0.001 ng/mL to 
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0.067 ± 0.028 ng/mL), and values returned to baseline 1 day after the 
trail (Figure 2). However, the average values of cTnI were highly 
biased, because participant number 7 showed an almost 10-fold 
increase in cTnI serum concentration 1 hour after the competition, 
which remained around 4-fold elevated 24 and 48 hours after the start 
of the MUM (Table 1). A nonsignificant slight increase in average 
FM serum concentration was observed 1 hour after the competition 
(from 1508 ± 222 g/L to 1731 ± 204 g/L), which remained stable 
until 24 hours after the beginning of the competition (1744 ± 250 
g/L) and returned to baseline values at 48 hours (1520 ± 318 g/L) 
(Figure 1). Average FM serum values of all time points analyzed were 
in the previously established normal range (> 1000 g/L).11 Finally, 
no changes in SM were found until 24 hours after the start of the 
MUM, when SM serum concentration rose significantly from 1443 ± 
390 g/L to 3743 ± 1110 g/L (ES = 1.34). SM serum activity 
remained nonsignificantly elevated 48 hours after the initiation of the 
competition (2828 ± 762 g/L). Average baseline SM serum levels 
were in the normal range (> 2000 g/L).11 (Figure 2). The SM serum 
peak at 24 hours after the start of the MUM was also highly correlated 
with the CK serum peak found 1 hour after the competition (r = .884; 
P = .004) (Figure 3). Finally, SM was not correlated with cTnI. 
\<<<<<<<<<TABLE 1>>>>>>>>>>>>>\ 
\<<<<<<<<<FIGURE 2>>>>>>>>>>>>>\ 
\<<<<<<<<<FIGURE 3>>>>>>>>>>>>>\ 
Discussion 
To our knowledge, this is the first study to assess the utility of the 
myosin isoforms SM and FM as serum biochemical markers of fiber-
specific muscle damage induced by a MUM in experienced endurance 
runners. SM and FM were compared against CK, a widely used 
biomarker of exercise-induced muscle damage, and cTnI, a specific 
biomarker of cardiac damage. The novel finding of the current study 
was that only SM serum levels were significantly raised, while FM 
serum levels remained almost unaltered after the MUM competition. 
Another remarkable finding was that CK and SM serum peaks were 
highly correlated. 
In the absence of myocardial infarction, muscle injury, or 
disease, large and time-sustained increases in blood CK activity have 
been widely accepted as a biomarker of muscle damage.17 As 
expected, the MUM induced large increases in CK serum levels, up to 
an almost 16-fold rise 1 hour after the competition. Significant CK 
serum increases in healthy and well-trained participants have been 
previously documented after MUM competitions.5 Large variability in 
serum CK concentrations among participants is common and has been 
previously described in experienced ultramarathoners after 24 hours 
of treadmill running18 and after a 166-km MUM.6 The reason for this 
variability still remains unclear, but it has been suggested that 
susceptibility is mainly related to genotype characteristics.19 The CK 
serum peak 1 hour after the MUM and its recovery over the following 
48 hours were also consistent with previous studies.6 However, CK 
levels provide a gross indication of muscle-fiber damage, because 
they cannot identify the magnitude of damage20 or the type of fibers 
affected.7 
Although direct evidence of muscle damage is histological, 
force-generating capacity is considered a reliable and valid marker of 
muscle damage.21 It has moreover been demonstrated that running a 
MUM induces large decreases in the knee-extensor force-generating 
capacity (a 35% decrease after a 166-km MUM), which are related to 
fatigue and muscle damage.6 Furthermore, different studies have 
recently proposed sarcomere proteins such as troponin as proxy fiber-
type-specific biomarkers of muscle damage.7,22 According to the 
observed time course, molecular mass, and fiber compartment in 
which these proteins are located, their elevation in serum suggests 
more severe damage, signifying sarcomere damage.22 As fiber-type-
specific sarcomere proteins, SM and FM could allow for indirect 
diagnosis of sarcomere damage and the type of fiber affected.11 
Because MUM running has been demonstrated to induce muscle 
damage,6 the significant increases in SM serum concentration seen 24 
hours after the start of the MUM suggested selective slow (type I) 
fiber damage, and due to its elevated molecular weight (493 kDa) and 
its fiber intrasarcomeric compartmentalization, increased serum SM 
could indicate sarcomere disruptions of those fibers. Moreover, since 
cTnI showed a nonsignificant serum increase 1 hour after the 
competition and returned to almost baseline values 24 hours after the 
beginning of the MUM, SM serum increases in healthy individuals 
can be mainly related to skeletal-muscle slow-fiber damage, rather 
than myocardial damage. Furthermore, there was no statistical 
relationship between SM and cTnI. However, further research is 
needed on cTnI and the distance of ultraendurance events, because the 
only participant who completed the whole MUM (participant number 
7) showed the highest increases in cTnI in every sample analyzed 
after the competition. 
No changes in FM serum concentration were seen after the 
MUM, which indicates that the fast fibers suffered no damage or, at 
least, less damage than the slow fibers. Certainly, it has been proved 
by histology that fast fibers are most susceptible to eccentric 
contractions,23 and downhill running, which is a mainly eccentric 
activity, induces muscle damage.4 However, since endurance runners 
have greater levels of slow (type I) fibers,14,15 it is reasonable to 
assume that slow (type I) fibers are predominantly recruited and 
damaged during a MUM. However, the hypothesis that a MUM also 
induces fast (type II) -fiber damage cannot be completely ruled out 
because CK is non–fiber-type-specific. Moreover, baseline FM serum 
levels were over the previously described normal range,11 a 
phenomenon that can be attributed to the type of training (higher 
intensity and less volume) performed by the runners the week before 
the race, but this is only speculation. Future studies in this area should 
carefully analyze the training strategies used the week before the 
competition. 
Due to its mainly sarcoplasmic location, CK is thought to 
indicate increased membrane permeability after membrane 
disruptions at early time points24 and the peroxidation of membrane 
lipids caused by an increase in reactive oxygen species and the 
activation of ion (Na+ and Ca2+) channels for several days after 
exercise.25 The peak value for CK serum was found 1 hour after the 
MUM. This could be explained by the long duration of the 
competition, causing a significant degree of membrane damage 
during the run.26 It has been demonstrated that the resealing of 
artificially produced membrane disruptions occurs in less than a 
minute,27 but CK efflux may occur during the run due to a continuous 
process of membrane disruption followed by rapid resealing. The CK 
serum peak post-MUM and its recovery kinetics over the following 2 
days were consistent with previous studies.6 Nevertheless, the average 
1-hour post-MUM CK serum peak was lower than that found after 
longer distance races.28 In this respect, and according to Waskiewicz 
et al,28 since the volume of exercise increases the metabolic demands 
for intracellular Ca2+,
26 and it is associated with muscle-damage 
indices, it seems reasonable to assume that augmented membrane 
permeability is related to the distance covered, as can be seen in Table 
1. While participants 2 and 3, who completed 26 km, showed mild 
increases in serum CK activity post-MUM, participant 7, the only one 
who completed the whole MUM (~85 km), presented the greatest 
increases in CK serum activity after the competition. In contrast, 
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exercise intensity, expressed as average speed (km/h) at which the 
participants ran the MUM, showed no trend, since participants left the 
competition at different points along the route (see Table 1). Further 
research with a larger sample is therefore needed in this area to clarify 
the relationship between biochemical markers of muscle damage and 
both distance (km) and average speed (km/h). 
Myosin isoforms have a different serum time course than CK.11 
Sarcomere-protein turnover is longer than that of sarcoplasm 
proteins,29 so the SM serum peak 1 day after the MUM can be 
explained by the increased activity of calpain 2 days after exercise.30 
Calpain is a Ca+2-dependent protease. The long duration of the MUM 
may have led to large increases in intracellular Ca+2 during the run, 
which would accelerate calpain degradation and lead to the significant 
increases in SM serum 1 day after the MUM. Calpain removes 
myosin from the filamentous structure of the sarcomere.31 At this 
time, increased membrane permeability due to the activation of 
stretch-activated ion channels25 could lead to a release of large 
proteins into the interstitium. Once in the interstitial space, proteins 
are mainly transported via the lymphatic system into the bloodstream, 
because the capillary membranes in skeletal muscle are almost 
impermeable to proteins.7–32 The muscle-fiber compartment in which 
SM is located and its complex degradation process could explain the 
delayed increases in serum of SM. 
Finally, CK and SM serum peaks occurred with 1-day 
difference but were strongly correlated. Membrane damage could 
accompany sarcomere disruptions, due to the tight connection 
between myofibrils, cytoskeleton, and membranes.33 Therefore, it 
seems that membrane damage could be related to subsequent fiber 
sarcomere disruption of slow fibers. 
Practical Implications 
The current study shows that SM could provide indirect information 
about fiber-type-specific sarcomere damage 1 day after a MUM, and 
since the serum peak of myosin isoforms is not reached until 1 day 
after a MUM, they could be used in diagnoses that are not made 
immediately after the competition. Although fiber specificity cannot 
be determined by CK, its serum activity 1 hour after a MUM seems to 
be related to the subsequent SM serum response. MUM trainers and 
runners should be aware that the total distance covered could be 
related to muscle damage, and sharp SM serum increases suggest that 
a longer recovery may be needed. Further research regarding MUM 
distance covered, training and performance variables, and damage 
degree inflicted to skeletal-muscle slow (type I) fibers is needed. 
Conclusions 
In summary, since there is evidence of muscle damage after 
prolonged mountain running, an increase in SM serum concentration 
after a MUM could be indirect evidence of selective slow (type I) -
fiber-specific sarcomere disruptions. 
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Figure 1 — Altitude profile of the entire mountain ultramarathon and the distance scale.  
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Figure 2 — Changes in (a) serum concentration of creatine kinase (CK) 
(n = 8), (b) slow myosin (SM) (n = 8), and (c) skeletal-muscle fast 
myosin (FM) (n = 7) 1 day before the competition (pre), less than 1 hour 
after finishing the competition (post), and 1 and 2 days after the mountain 
ultramarathon. Data are normalized (mean ± standard error of the mean) 
to pre-mountain-ultramarathon values (100%). **Significantly different 
from preexercise value at P < .01.  
 
Figure 3 — Association between serum creatine kinase (CK) (natural 
log) peak activity 1 hour after finishing the long-distance trail competition 
(post) and slow myosin (SM) (natural log) peak concentration 24 hours 
after the start of the mountain ultramarathon (n = 8). r, Pearson 
correlation coefficient.  
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Table 1 Concentrations of Serum Creatine Kinase, Slow Myosin, and Cardiac Troponin I 1 Day Before the Competition (Pre), Less Than 1 
Hour After Finishing the Competition (Post), and 24 and 48 Hours After the Beginning of the Mountain Ultramarathon for Each Participant 
 
    Creatine Kinase (U/L)  Slow Myosin ( g/L)  Cardiac Troponin I (ng/mL) 
Participant Gender km Time (h:min:s) Av speed (km/h) Pre Post 24 h 48 h  Pre Post 24 h 48 h  Pre Post 24 h 48 h 
1 M 41 09:39:18 4.25 70 793 933 611  856 703 1674 1333  0.017 0.029 0.017 0.017 
2 M 26 06:47:33 3.83 108 363 356 214  811 920 1741 1832  0.017 0.022 0.017 0.017 
3 M 26 06:47:16 3.83 156 350 196 126  628 505 1233 963  0.017 0.040 0.017 0,017 
4 M 41 09:10:12 4.47 74 2691 1118 468  3097 3159 9812 5543  0.018 0.034 0.017 0.018 
5 M 53 10:26:24 5.08 173 856 553 259  842 1225 1928 1162  0.017 0.029 0.017 0.017 
6 M 53 12:09:28 4.36 179 2542 1156 531  3338 3205 4553 3979  0.017 0.079 0.017 0.017 
7 F 85 11:48:48 7.26 233 7643 5819 2722  988 1404 6999 6361  0.027 0.260 0.115 0.101 
8 M 53 12:09:32 4.36 59 1175 626 288  984 1400 2007 1454  0.017 0.043 0.017 0.017 
Abbreviations: M, male; F, female; km, kilometers of mountain ultramarathon completed; Av, average. 
